Coreline Soft Launches AI Infrastructure for Germany's Lung Cancer Screening

Coreline Soft, a global player in medical AI, has introduced a new AI infrastructure to align with Germany's lung cancer screening program. This launch coincides with the program's full implementation in April 2026, where AI-aided analysis is mandatory for reimbursement under the statutory health insurance system.

The screening initiative requires compliance with core guidelines such as double reading, quality assurance, and GDPR-compliant data handling. Coreline's AVIEW HUB caters to these needs by offering integrated workflows to manage multi-site reading collaborations and discrepant diagnosis resolutions via consensus processes.

AVIEW HUB stands out by standardizing AI-supported detection and workflow management, minimizing interpretative variability, and enabling scalable operations. A demonstration of AVIEW HUB will be presented at RöKo 2026, showcasing its operational expertise rooted in established German institutions.